References
- Uretsky B F, Farquhar D S, Berezin A F, Hood W B, Jr. Symptomatic myocardial infarction without chest pain: Prevalence and clinical course. Am J Cardiol 1977; 40: 498–503
- Lee T H, Rouan G W, Weisberg M C, Brand D A, Cook E F, Acampora D, Goldman L. Sensitivity of routine clinical criteria for diagnosing myocardial infarction within 24 hours of hospitalization. Ann Intern Med 1987; 106: 181–86
- Boyd J C. Mathmatical models for demonstrating clinical usefulness of biochemical markers. Scand J Clin Lab Invest 1997; 57: 46–63, (Suppl 227)
- Jorgensen J S, Pedersen J B, Pedersen S M. Use of neural networks to diagnose acute myocardial infarction. I. Methodology. Clin Chem 1996; 42: 604–612
- Keffer J H. Myocardial markers of injury: evolution and insights. Am J Clin Pathol 1996; 105: 305–20
- Christenson R H, Azzazy H ME. Biochemical markers of the acute coronary syndromes. Clin Chem 1998; 44: 1855–1864
- Roberts R. Early diagnosis of myocardial infarction with MB isoforms. Clin Chim Acta 1998; 272: 33–45
- Wu A HB, Lane P L. Metaanalysis in clinical chemistry: validation of cardiac troponin T as a marker for ischemic heart diseases. Clin Chem 1995; 41: 1228–33
- Selker H P, Zelenski R J, Antman E M, Aufderheide T P, Bernard S A, Bonow R O, Gibler W B, et al. An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a national heart attack alert program working group. Ann Emerg Med 1997; 29: 13–87
- Ingwall J S, Kramer M F, Fifer M A, Lorell B H, Shemin R, Grossman W, Allen P D. The creatine kinase system in normal and diseased human myocardium. N Engl J Med 1985; 313: 1050–4
- de Winter R J, Koster R W, Sturk A, Sanders G T. Value of myoglobin, troponin T, and CK-MB mass in ruling out myocardial infarction in the emergency room. Circulation 1995; 92: 3401–3407
- Tucker J F, Collins R A, Anderson A J, et al. Early diagnostic efficiency of cardiac troponin I and troponin T for acute myocardial infarction. Acad Emerg Med 1997; 4: 13–21
- Katrukha A G, Bereznikova A V, Filatov V L, Esakova T V, Kolosova O V, Petterson K, et al. Degredation of cardiac troponin I: implications for reliable immunodetection. Clin Chem 1998; 44: 2433–40
- Wu A HB, Feng Y J, Moore R, Apple F S, McPherson P H, Buechler K F, Bodor G. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comprison of assays for troponin T and I. Clin Chem 1998; 44: 1198–208
- Adams J E, Schechtman K B, Landt Y, Ladenson J H, Jaffe A S. Comparative detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem 1994; 40: 1291–1295
- Jaffe A S, Landt Y, Parvin C A, Abendschein D R, Geltman E M, Ladenson J H. Comparative sensitivity of cardiac troponin I and lactate dehydrogenase isoenzymes for diagnosing acute myocardial infarction. Clin Chem 1996; 42: 1770–1776
- Package Insert. Stratus Cardiac Troponin-I Fluorometric Enzyme Immunoassay, Copyright 1998. Dade Behring Inc
- Christenson R H, Apple F S, Morgan D L, Alonsozana G L, Mascotti K, Olson M, et al. Cardiac troponin I measurement on the ACCESS® immunoassay system: analytical and clinical performance characteristics. Clin Chem 1998; 44: 494–501
- Baum H, Braun S, Gerhardt W, Gilson G, Hafner G, Muller-Bardorff M, Stein W, et al. Multicenter evaluation of a second-generation assay for cardiac troponin T. Clin Chem 1997; 43: 1877–84
- Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996; 93: 1651–7
- Hamm C W, Heeschen C, Goldmann B U, Barnathan E, Simoons M L. Value of troponins in predicting therapeutic efficacy of Abciximab in patients with unstable angina. Abstract. JACC 1998; 31: 185A.
- Antman E M, Tanasijevic M J, Thompson B, Schactman M, McCabe C H, Cannon C P, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335: 1342–9
- Clyne C A, Medeiros L J, Marton K I. The prognostic significance of immunoradiometric CK-MB assay (IRMA) diagnosis of myocardial infarction in patients with low total CK and elevated MB isoenzymes. Am Heart J 1989; 118: 901–6
- Ohman E M, Armstrong P W, Christenson R H, Granger C B, Katus H, Hamm C W, et al. Risk stratification with admission cardiac troponin T levels in acute myocardial ischemia. N Engl J Med 1996; 335: 1333–41
- Newby L K, Christenson R H, Ohman E M, et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. Circulation 1998; 98: 1853–1859
- Christenson R H, Duh S H, Newby L K, Ohman E M, Califf R M, Granger C B, et al. Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. Clin Chem 1998; 44: 494–501
- Olatidoye A G, Wu A HB, Feng Y J, Waters D. Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies. Am J Cardiol 1998; 81: 1405–1410
- Hamm C W, Goldmann B U, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997; 337: 16